16399965

Source:http://linkedlifedata.com/resource/pubmed/id/16399965

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012222, umls-concept:C0040615, umls-concept:C0332281, umls-concept:C1456613, umls-concept:C1521761
pubmed:issue	1
pubmed:dateCreated	2006-1-9
pubmed:abstractText	When new medications are introduced, a period of diffusion, evaluation, and adoption follows. This study evaluated the influence of patient- and facility-level characteristics on the early use of a new antipsychotic, ziprasidone, among Department of Veterans Affairs (VA) patients with schizophrenia.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16399965-16525009
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502838
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/ziprasidone
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1075-2730
pubmed:author	pubmed-author:BlowFrederic CFC, pubmed-author:DalackGregory WGW, pubmed-author:IgnacioRosalinda VRV, pubmed-author:McCarthyJohn FJF, pubmed-author:StavengerThomasT, pubmed-author:ValensteinMarciaM
pubmed:issnType	Print
pubmed:volume	57
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	70-6
pubmed:dateRevised	2006-10-13
pubmed:meshHeading	pubmed-meshheading:16399965-Aged, pubmed-meshheading:16399965-Algorithms, pubmed-meshheading:16399965-Antipsychotic Agents, pubmed-meshheading:16399965-Drug Approval, pubmed-meshheading:16399965-Drug Therapy, pubmed-meshheading:16399965-Drug Utilization Review, pubmed-meshheading:16399965-Female, pubmed-meshheading:16399965-Humans, pubmed-meshheading:16399965-International Classification of Diseases, pubmed-meshheading:16399965-Male, pubmed-meshheading:16399965-Mental Health Services, pubmed-meshheading:16399965-Middle Aged, pubmed-meshheading:16399965-Piperazines, pubmed-meshheading:16399965-Registries, pubmed-meshheading:16399965-Schizophrenia, pubmed-meshheading:16399965-Thiazoles, pubmed-meshheading:16399965-United States, pubmed-meshheading:16399965-United States Department of Veterans Affairs, pubmed-meshheading:16399965-Veterans
pubmed:year	2006
pubmed:articleTitle	Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.
pubmed:affiliation	SMITREC/VA Ann Arbor Center for Excellence, P.O. Box 130170, Ann Arbor, Michigan 48113-0170, USA. marciav@med.umich.edu
pubmed:publicationType	Journal Article